Prevention of Recurrence and Metastasis of Colorectal Cancer by Comparing Huaier With Capecitabine Monotherapy

PHASE4RecruitingINTERVENTIONAL
Enrollment

756

Participants

Timeline

Start Date

October 18, 2024

Primary Completion Date

July 31, 2027

Study Completion Date

November 30, 2029

Conditions
Colorectal Cancer
Interventions
DRUG

Huaier granule

Oral administration, 10g once, 3 times a day, starting within 14 days-2 months after surgery. Please refer to the medication manual for specific usage.

DRUG

Capecitabine

Oral administration, 1250mg/m\^2, twice a day (2500mg/m\^2/d),day 1-14,with one course of treatment every 3 weeks, for a total of 4-6 courses.

Trial Locations (9)

150081

NOT_YET_RECRUITING

Harbin Medical University Cancer Hospital, Harbin

200025

RECRUITING

Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai

200032

RECRUITING

Sanjun Cai, Shanghai

200127

NOT_YET_RECRUITING

Renji Hospital,Shanghai Jiao Tong University School of Medicine, Shanghai

210029

RECRUITING

Jiangsu People's Hospital, Nanjing

213000

NOT_YET_RECRUITING

The First People's Hospital of Changzhou, Changzhou

225001

RECRUITING

Northern Jiangsu People's Hospital, Yangzhou

310005

NOT_YET_RECRUITING

Zhejiang Cancer Hospita, Hangzhou

315046

NOT_YET_RECRUITING

Ningbo Medical Center Lihuili Hospital, Ningbo

All Listed Sponsors
collaborator

Huazhong University of Science and Technology

OTHER

lead

Fudan University

OTHER